RARE Ultragenyx Pharmaceutical Inc.

RARE Ultragenyx Pharmaceutical Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $14.43 · VWAP $22.86 · -36.4% vs 12m avg buyer

collapse vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CFO, EVP sold $164.4K, Aug 4

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

RARE Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist RARE belongs to, members best 30-day change first — RARE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
View watchlist →
MRNA+49.7% -7.8%1d -3.1%7d PACB+29.1% -11.7%1d -25.8%7d IBRX+16.1% -8.2%1d -12.7%7d AMGN+14.9% -0.3%1d +4.3%7d ILMN+14.7% -2.0%1d -5.6%7d NTRA+13.9% -2.8%1d -1.8%7d RARE+12.9% -4.2%1d -6.1%7d LEGN+8.7% -6.7%1d -0.8%7d BIIB+7.7% -1.1%1d +3.1%7d GILD+5.8% -0.8%1d +3.3%7d ABSI+2.6% -7.1%1d -18.8%7d REGN+2.1% -0.7%1d +5.9%7d BEAM+1.6% -5.1%1d -8.7%7d ABCL+1.1% -6.9%1d -6.0%7d MEDP+0.3% -1.6%1d +1.1%7d NTLA-0.6% +0.7%1d -12.6%7d QTRX-1.4% -6.5%1d -12.5%7d ICLR-2.2% -2.8%1d +3.7%7d VRTX-2.6% -1.8%1d -2.0%7d ALNY-3.1% -0.9%1d -0.4%7d TXG-3.9% -3.5%1d -13.4%7d IONS-4.2% -2.7%1d -5.2%7d SDGR-5.6% -11.3%1d -17.2%7d CRSP-5.7% -4.4%1d -7.8%7d TWST-7.2% -8.1%1d -16.9%7d TEM-7.5% -9.0%1d -8.8%7d BNTX-8.5% -2.8%1d -9.5%7d RVMD-9.2% -6.0%1d -6.2%7d COGT-9.3% 0.0%1d -4.8%7d INCY-9.4% -0.2%1d +0.3%7d PTGX-9.9% -5.7%1d -10.4%7d KYMR-9.9% -3.1%1d -6.8%7d EDIT-13.3% -3.7%1d -19.0%7d SRPT-13.5% -3.9%1d -4.2%7d BMRN-15.5% -2.4%1d -0.2%7d ARGX-16.8% -3.2%1d -0.7%7d NKTR-46.9% -5.1%1d -13.1%7d
@biotech-scan
View watchlist →
GRAL+56.9% -13.0%1d -16.2%7d MRNA+49.7% -7.8%1d -3.1%7d DNA+45.5% -12.7%1d -21.0%7d AMGN+14.9% -0.3%1d +4.3%7d ILMN+14.7% -2.0%1d -5.6%7d RARE+12.9% -4.2%1d -6.1%7d A+12.5% -1.5%1d +1.4%7d ISRGE+11.6% -0.3%1d +0.7%7d LLY+10.5% +0.4%1d +6.6%7d DHR+9.9% -1.1%1d +4.2%7d RXRX+8.8% -16.6%1d -20.4%7d ABBV+8.7% +0.7%1d +3.2%7d LEGN+8.7% -6.7%1d -0.8%7d BIIB+7.7% -1.1%1d +3.1%7d TMO+6.4% -0.9%1d +4.9%7d GILD+5.8% -0.8%1d +3.3%7d MDT+2.3% -0.7%1d +7.1%7d REGN+2.1% -0.7%1d +5.9%7d BEAM+1.6% -5.1%1d -8.7%7d IBB-0.2% -2.6%1d -2.2%7d NTLA-0.6% +0.7%1d -12.6%7d IQV-0.7% -1.5%1d +2.7%7d DXCM-1.5% -1.9%1d +2.3%7d IBBQ-1.9% -2.7%1d -2.6%7d VRTX-2.6% -1.8%1d -2.0%7d ALNY-3.1% -0.9%1d -0.4%7d IONS-4.2% -2.7%1d -5.2%7d CRSP-5.7% -4.4%1d -7.8%7d XBI-6.4% -3.6%1d -6.2%7d NVO-6.9% -1.0%1d +0.5%7d BNTX-8.5% -2.8%1d -9.5%7d COGT-9.3% 0.0%1d -4.8%7d INCY-9.4% -0.2%1d +0.3%7d PTGX-9.9% -5.7%1d -10.4%7d KYMR-9.9% -3.1%1d -6.8%7d EDIT-13.3% -3.7%1d -19.0%7d SRPT-13.5% -3.9%1d -4.2%7d BMRN-15.5% -2.4%1d -0.2%7d IMVT-26.5% -2.8%1d -12.3%7d NKTR-46.9% -5.1%1d -13.1%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jul 2 pass n/a Watched, not owned -27.0% complete

Next earnings RARE reports in 17 days Nov 3

Last report Aug 4

Reported the quarter ending 2026-06-30: revenue $214M, diluted EPS -$0.90, net income -$92M (SEC filing). Across the print the stock moved -0.4% (close before → first close after).

full note →

Against street estimates

How RARE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Oct 16

Result
Aug 4 -1.00-0.90+9.7%Beat
May 5 -1.46-1.54-5.7%Miss
Feb 12 -1.17-1.29-10.1%Miss
Nov 4 '25 -1.21-1.81-49.7%Miss
Aug 5 '25 -1.32-1.17+11.4%Beat
May 6 '25 -1.64-1.57+4.4%Beat
Feb 13 '25 -1.27-1.39-9.4%Miss
Nov 5 '24 -1.47-1.40+5.0%Beat

News (last pull)

Headlines about RARE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 29 days ago · Sep 18

RARE research tape

38 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Biotech Scan — October 16, 2026 scan Biotech Scan — October 9, 2026 scan Biotech Scan — October 2, 2026 scan Biotech Scan — September 25, 2026 scan Biotech Scan — September 23, 2026
Types
Oct 16 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNNVOIMVTIONSINCYALNYREGN +4 more
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 17 Market Brief The Session After the Hike Was the Broadest Up Day of the Month
AAUCABCLACGLALLYEALSNARWRSDGRGNRC +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 3 Market Brief Software Re-Rates, Semis Stay Home
AAPLABBNYALMSARBGBNORAREMSTR +4 more
Sep 3 Article Ultragenyx Phase 3 Aspire misses in Angelman syndrome — article
RARE
Sep 2 Scan Washout Turn Scan
AAAAUCACNAIALBALNYALTARMP +4 more
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 4 Catalyst RARE earnings
RARE
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 25 Scan Biotech Scan
CRSPBEAMNTLAALNYLEGNMRNABNTXLLY +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNBNTX +4 more
May 5 Catalyst RARE earnings
RARE
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 24 Scan Biotech Scan
ABBVALNYAMGNBIIBBMRNBNTXCRSPDHR +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNBNTXDHR +4 more